AKT1 and glioblastoma: Deregulation of receptor tyrosine kinases (RTKs), as well as dysregulated RAS-MEK-ERK, PI3K-AKT, p53, and Rb pathways are all seen in a majority of GBM patients, and have been proposed as a necessity for gliomagenesis [16].